IG Petrochemicals Ltd. Conducted their conference call today at 3:30 pm.
" To become a well diversified chemical company with leadership in PAN* Industry. "
Here are the key takeaways π...
Business Overview
- Company has given robust growth in both QoQ and YoY basis.
- They still maintain their position of being the largest manufacturer of phthalic Anhydride (PAN) and maleic anhydride.(MAN)
- With government demand being bullish on downstream products like Paints, Plasticizers, UPR and all , there will be demand of PAN in domestic markets.
- They have a positive correlation with the infrastructure industry leading to a strong demand growth.
- There is improvement in the integrated process have also boosted growth.
- Higher volume of PAN and MAN have reduced the cost to much lower levels.
- Their products are currently used in 20+ products.
- The Company is also focused towards other derivative Chemcials as well which comes in relation to business.
- And generate about 30% of revenue from them.
- The next step that Company is planning to take is green Chemistry
- Deep study is done, it will replace oil based paints ,and the company will allow business when every industry approves it with no government hindrance.
- They have concrete plan for it, green Chemistry is not in relation with PAN and MAN.
- India's demand is upwards sloping with more business opportunity for company. There has been jump in domestic demand to 90% of total sales which was around 70 - 80% long way back.
- Government benefits and PLI scheme are also been looked by the company for benefits.
- They keep a target to increase its clients base on regular basis for better growth.
- MAN demand is increasing a lot in india still no new capacity is available due to high Capex and less raw material availablity like n butain.
- It is used in various water based chemicals and works in all types of industry.
- They are likely to avail good global demand growth as there is demand and supply equilibrium of materials.
- With China +1 situation , various companies are at expansion across globe.
- With diversified chemical portfolios, Rather then major focus on margin, their focus is market driven.
- For price and margin point they are yet to hear updates from finance ministry for global businesses related to duty presence.
- The Company has based an estimate to see a growth of 6 to 7% from domestic market on avg 10 year period.
- There is decline in spread in April and May due to covid working environment. Demand will come back soon properly when market gets back normal.
- The companies peer in PAN business is not for outer sales But for self consumption, so they have low fear for that.
Financials
- During this Quarter the Pat levels has increased by 2425% and on yearly basis it's up by 801%.
- There was huge jump in EBITDA as well.
- The Company has made a prepayment of 42cr which was realted to the term loan obtained for PA-4 unit.
- Company has Operating conversion cost due to its state of the art facilities with push of innovation.
- They receive most of their orders from western region , where the gain upper hand due to strategic location.
- In total 69 cr of loan was paid out which have made DtoE = 1
- There has been a reduction in their tax levels from 35% to 20's range.
- They expect to become net debt free in upcoming 6 months.
- Company WC cycle is less then 40 days which is best in the total industry on Chemcials sector.
- For financial cost reduction, new banks model have been brought with presence of big banks like HDFC and other 2.
- In india, as lowest producer in PAN , they can grow easily at 8%. And as plants are increased with centralised work there is a lot of saving.
- For above 3 banks are here for PA4 , good balance of psu and private banks will help us avail lower interest.
- For term loan, the company has cost of 2 cr or less which will be met.
- This don't need to worry about Raw material supply as major of that is been received from Reliance due to their correct location this have made their operational cost lower.
- Reliance additional capacity is provings supply, in Singapore there is Exxon so there is availablity.
- Company has witnessed increased in employees cost due to some employees retirement for which provisions were been made.
- There has been a change in their catalyst as well in previous Quarters.
Capex and capacity
- There has been an capacity addition of phthalic Anhydride at PA4 unit. It have reached its optimal untilisation.
- Advance Plasticiser is expected by the company to begin in June 21 looking at covid situation.
- This Plasticiser plants estimate cost is 40cr
- Another Greenfield project is in the plan of Company to increase its PAN capacity by 80,000 MTPA along with boost to other products.
- For this company has made an estimation of 600cr which is spread in 3 years before commissioning.
- The application with environment ministry is done and detailed engineering is been carried out, once environment clearing out they will start at optimal levels.
- Currently all their plants are working at optimum capacity.
- Upgrade plant will make a total about 220000 MTPA of PAN AND about 7660 MTPA of MAN.
- For n butain plant even with tax deduction they still face difficult due to the present supply mismatch of material and not just that the cost is 2 times their predicted sales.
- On global level, Capex is Majorly done in India and China, apart from it there is no new from other countries.
For more discussion on Equity research and OI analysis
Balaji Amines conducted their Conference Call today at 4:00 pm.
Here are the key takeaways π
Business Updates:
β’ EBIDTA growth- 78% Driver were increasing demand and improving price realization.
β’ Zero debt co. on standalone basis.
β’ Certain product are now exported to China.
Ethylamines:
β’ With implementation of new technology the cost of production is expected to lower.
β’ Demand is India is expected to increase by 12-15% over years.
β’ Import of Ethylamines is 9,000 Tones in India.
β’ Majority will be sell directly in market.
Godawari Power & Ispat conducted their conference call today at 12 noon
"Co. is targeting to be debt free company soon"
Here are the key takeaways π
Business Updates:
β’ In- plant power generation capacity of 73 MW
β’ Thermal Power is yielding 12%, hence co. is expanding in Solar Pvr
β’ Utilization level- 92-95%
β’ Iron Ore availability is expected to consistent from this year
β’ MOU signed with Chattigarh for future project
Solar PV Power:
β’ Setting up a 250 MW captive Solar PV power plant to replace existing thermal capacity.
β’ Project will commissioned in Q3 Fy 2023.
β’ Project Dynamics of project mentioned in image
β’ Expected returns is 24%, hence now Godawari is investing heavily.
Indoco Remedies Ltd. Conducted their conference call today at 3:30 pm.
" Company motivated to earn 19% above CAGR"
Here are the key takeaways π
Business Overview
- Company have nominal profit on YoY basis and has experienced a decline in growth on QoQ basis.
- Company still remains bullish on their key segments for further growth.
- The major impacted acute segment witness strong hit due to fall in demand.
- The Company experience about 20% de growth in the prescription buisness. And as the covid situation is falling apart they will be able to cover up the losses.
- Their Domestic business has taken the major hit this quarter but was covered somewhat by international growth.
Alkem Laboratories conducted their conference call today at 4:30.
"Guidance for EBIDTA margins to be around 20%"
Here are the key takeaways π
Business Update:
β’ India business grew 17.1% YoY.
β’ Therapy segment grew well, of which major contribution of growth is Anti-Diabetic, Neuro, Vitamins, Gastro.
β’ In this quarter Alkem has filed 4 new ANDA and received 10 approvals.
FY21- 9 ANDA filed with 25 approval.
Gross Margin:
β’ Inventory Provision of 80 cr was taken, which declined margins.
β’ In More than 6 months inventory, if NRV seems to be unrecognizable, provision is made.